NORMAN, OKLA. – The University of Oklahoma officially unveiled a new microscope that enables advanced research capabilities during a grand opening on Thursday, Dec. 5.
“This Tundra cryo-transmission electron microscope is the first of its kind here at OU and in the state of Oklahoma. And, since it is a relatively new instrument, there are only a handful in the nation,” said Ann West, director of the Oklahoma Center for Biomedical Research Excellence in Structural Biology. “This microscope will allow researchers to complete single particle analysis for macro-molecular structure determinations.”
A cryo-TEM allows scientists to examine extremely small things, like proteins or viruses, in their natural state. The instrument passes an electron beam through a thin, frozen sample and captures detailed 2D images. Multiple 2D images can then be combined to produce 3D reconstructions that reveal atomic-level details.
“It’s very exciting that this instrument will be part of the core user facility of the Sam Roberts Noble Microscopy Lab. This technology will support many current and future students,” said SRNML Director Andrew Elwood Madden.
This facility was made possible through collaborative support from the Office of the Vice President for Research and Partnerships, the SRNML and COBRE.
Others present at the ceremony who will be involved in the use of the Tundra cryo-TEM include COBRE Biomolecular Structure Core Director Len Thomas, SRNML Research Scientist Julian Sabisch and SRNML Research Associate Preston Larson.
Learn more about COBRE, the SRNML and the Tundra cryo-TEM.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
Raid Aljumaily, M.D., an associate professor of hematology-oncology at the University of Oklahoma College of Medicine, is the national co-leader of the PROSPECT-Lung clinical trial that will evaluate the timing of immunotherapy for patients with operable non-small cell lung cancer.
Recently published research from the University of Oklahoma and the University of Tulsa shows that a new therapy for children with chronic nightmares reduced the number of nightmares and the distress they caused and increased the number of nights a child slept without waking.
Belinda Higgs Hyppolite, Ed.D., vice president of the Division of Access and Opportunity and associate provost at the University of Oklahoma, and June Abbas, Ph.D., director of the School of Library and Information Studies in the Dodge Family College of Arts and Sciences, are among the top women leaders of Oklahoma, according to Women We Admire.